Quantcast

Latest Echo Therapeutics Inc. Stories

2014-03-20 12:32:35

Conference Call to begin at 9:00 a.m. ET PHILADELPHIA, Pa., March 20, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it will release financial results for the year ended December 31, 2013 on Thursday, March 27, 2014. Management will hold a conference call to review the company's 2013 performance starting at 9:00 a.m. ET...

2014-03-06 08:30:51

PHILADELPHIA, March 6, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, is pleased to announce that its clinical study of Symphony was selected for poster presentation at the 34(th) International Symposium on Intensive Care and Emergency Medicine (ISICEM) from March 18-21, 2014 in Brussels, Belgium. The study will be presented by the...

2014-03-03 08:31:14

PHILADELPHIA, March 3, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that Robert F. Doman, Executive Chairman and Interim CEO of Echo Therapeutics, will present at the upcoming 26(th) Annual ROTH Capital Conference. Mr. Doman will make a corporate presentation to prospective corporate partners and investors at 8:00...

2014-02-28 08:25:12

PHILADELPHIA, Feb. 28, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that Michael M. Goldberg, M.D., has been appointed to Echo's Board of Directors. "We are pleased to welcome Michael to the Board of Directors and look forward to working with him to optimize shareholder value," commented Robert F. Doman, Executive...

2014-02-06 08:28:16

PHILADELPHIA, Feb. 6, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that Robert F. Doman, Echo's Executive Chairman and Interim CEO, will participate in the Leerink Swann 2014 Global Healthcare Conference in New York, New York. Mr. Doman will make a corporate presentation to prospective corporate partners and...

2014-01-15 08:27:52

PHILADELPHIA, Jan. 15, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that Robert F. Doman, Executive Chairman and Interim CEO of Echo Therapeutics, will present at "TEN", Noble Financial Capital Markets' Tenth Annual Equity Conference. Mr. Doman will make a corporate presentation to prospective corporate partners and...

2014-01-14 08:28:55

PHILADELPHIA, Jan. 14, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that Thomas Bishop has joined Echo Therapeutics' management team as Vice President of Product Development. Mr. Bishop, an accomplished product development executive with more than thirty years' experience, joins Echo at a critical stage in the...

2014-01-13 08:29:47

PHILADELPHIA, Jan. 13, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony(®) CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it has submitted a Conformite Europeenne (CE) Mark Technical File to its European Notified Body to obtain market approval for its Symphony CGM System in the hospital critical care environment. CE Marking indicates a medical device's compliance...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related